Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Form Follows Function: A New Paradigm of Pancreatic Cancer Progression.

bioRxiv : the preprint server for biology·2025
Same author

Toward equitable major histocompatibility complex binding predictions.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

A Novel HOXA10-Associated 5-Gene-Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Ductal Adenocarcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2023
Same author

Engineering an ACE2-Derived Fragment as a Decoy for Novel SARS-CoV-2 Virus.

ACS pharmacology & translational science·2023
Same author

Cross-Reactive T Cell Response Exists in Chronic Lymphocytic Choriomeningitis Virus Infection upon Pichinde Virus Challenge.

Viruses·2022
Same author

Variant calling enhances the identification of cancer cells in single-cell RNA sequencing data.

PLoS computational biology·2022

Related Experiment Video

Updated: Jul 7, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

12.4K

VIPER: Virus Inhibition Via Peptide Engineering and Receptor Mimicry.

Anna Sophie Klingenberg1, Dario Ghersi2

  • 1Department of Information Systems and Quantitative Analysis, University of Nebraska at Omaha, Omaha, Nebraska, USA.

Journal of Computational Biology : a Journal of Computational Molecular Cell Biology
|February 14, 2025
PubMed
Summary

We developed VIPER, a computational method to design decoy peptides that block viral entry by mimicking host receptors. This approach accelerates the development of novel antiviral inhibitors.

Keywords:
computational drug designentry inhibitorpeptide engineeringstructural bioinformatics

More Related Videos

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

9.3K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K

Related Experiment Videos

Last Updated: Jul 7, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

12.4K
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

9.3K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K

Area of Science:

  • Structural biology
  • Computational virology
  • Drug discovery

Background:

  • Viral infections rely on protein-protein interactions between viral proteins and host receptors for cell entry.
  • Inhibiting these interactions is a crucial strategy for developing antiviral therapies.

Purpose of the Study:

  • To introduce Virus Inhibition via Peptide Engineering and Receptor Mimicry (VIPER), a novel computational approach.
  • To automate the design and optimization of biomimetic decoy peptides for inhibiting viral entry.

Main Methods:

  • Leveraging structural data from human-pathogen protein complexes.
  • Utilizing computational tools for structural biology and molecular dynamics simulations.
  • Designing peptides that mimic natural host receptor binding sites.

Main Results:

  • VIPER successfully generated decoy peptides capable of competitively inhibiting viral entry.
  • Computational validation demonstrated the approach's efficacy on three clinically relevant viruses.
  • The method focuses on reproducibility and extensibility for rapid antiviral development.

Conclusions:

  • VIPER offers a powerful, automated platform for designing novel antiviral inhibitors.
  • The approach has the potential to significantly accelerate therapeutic development against viral infections.
  • Biomimetic decoy peptides designed by VIPER represent a promising strategy for future antiviral interventions.